--------------------------------- Join Us! ----------------------------
This year’s roundtable will convene leaders across the healthcare sector to define metrics for advancing transparency, trustworthiness, and patient centricity in medicines development, focusing on the role of the pharmaceutical sector. The discussion will also spotlight and align participants’ ongoing efforts in these areas. Insights from the roundtable may shape future agenda-setting and metrics for the 
Good Pharma Scorecard
.
------------------------------------- Agenda ------------------------------------
8-8:30am
 
Breakfast + Registration
8:30-8:40 
Welcome.
 Jeremy Abbate, Publisher, Scientific American · Arda Ural, Head, Life Sciences, Americas, EY · Lauren Rogge, Principle, Climate Change and Sustainability, EY
8:40-8:55 
Keynote
. 
Yele Aluko
, Chief Medical Officer, EY Americas, 
Reaffirming its Social Contract: BioPharma’s Commitment to Transparency, Accountability and Public Trust
8:55-9:05m 
Setting the Stage. Jennifer Miller
, Co-Director, Program for Biomedical Ethics, Associate Professor, Yale School of Medicine; President, Bioethics International; Founder, Good Pharma Scorecard.
9:05-9:25 
Keynote. 
Robert Califf,
 Former FDA Commissioner, Duke Clinical Research Institute, Duke University School of Medicine, 
Advancing patient and population health responsibly: Essential commitments for BioPharma
9:25-10:30 
Establishing a Global Industry Reporting Standard for Clinical Research Data: Public health, ethics, and business considerations in response to 
Declaration of Helsinki revisions
Moderator. David Leventhal 
*
Francesca Scotti, Clinical Trial Information System, Transparency Lead, EMA 
*
Vasee Moorthy, Senior Advisor, R&D, World Health Organization 
*
Arthur Caplan, NYU School of Medicine *
Ben Rotz, AVP, Global Medical Policy, Strategy & Operations, Eli Lilly 
*
Morgan Hanger, Executive Director, CTTI, Duke School of Medicine 
*
10:30-10:45 Break
10:45-11:55
 
Enhancing Clinical Demographics in Research.
 
This session will examine FDA expectations, stakeholder priorities, and industry performance trends related to demographic representation in clinical trial enrollment. Panelists will explore strategies linked to success and consider whether incorporating leading indicators into the 
Good Pharma Scorecard
 could help recognize and accelerate further improvement.
Moderator. Cris Woolston, Sanofi 
*
Melissa Penn, Director, Patient Engagement R&D, Bayer *confirmed
Ivy Kam, Director DEI Sciences, Regeneron 
*
Lorena Kuri, Global Clinical Trials Strategy and Operations, Bristol Myers Squibb
Andrew Whitehead, BMS
 
*
Osa Eisele, MD, MPH, Head, Representation in Clinical Research, Amgen
Martin Mendoza, Chief Health Population Health Officer, CMS
Tricha Shivas, Chief of Staff and Strategy, Foundation for Sarcoidosis Research
Cary Gross, Professor of Medicine and Public Health, Yale School of Medicine
Pierre Theodore, Executive Director Health Equity, Genentech 
*
Silke Schoch, Director, Research & Programs, National Health Council 
*
11:55-12:15
 
The Bioethics Leadership Forum
 (BLF). What is it and how to get involved?
12:15-12:40 Lunch Break
12:40-12:55 
Keynote 
– Mark McClellan, Former FDA Commissioner, Duke-Margolis Institute for Health Policy
12:55-2pm 
Access to medicines in LMICS: Ethical considerations, barriers, facilitators + global trends
Moderator: Amy Israel, Senior Advisor, Access to Medicines, Union for International Cancer Control (UICC)
Mary Ann Slack, Former Director, FDA Center for Drug Evaluation and Research (CDER)
Vibhooti Ashar, Global Market Access & Pricing, BMS
Alex Schmidt, Head, Vaccine Development, Bill & Melinda Gates Medical Research Institute
2:05pm -3:15 
Patient Centricity in the Pharma Sector: Identifying a Consistent Set of Metrics & the Role of the Good Pharma Scorecard
Moderator: Cosmina Hogea, Global Patient Focused Implementation Science, Gilead
Alan Balch, CEO, Patient Advocate Foundation; National Patient Advocate Foundation
Sneha Dave, Generation Patient 
*confirmed
Linda Kollmar, AVP Patient Innovation and Engagement, Merck
Luther T. Clark, Executive Director, Patient Innovation & Engagement, V&I Global Medical and Scientific Affairs, Merck Research Laboratories
*
Ronika Alexander-Parrish, Director, US Medical Affairs, Pfizer
Mat Phillips, Associate Director, Patient View
Pat Furlong, CEO, Parent Project Muscular Dystrophy
Ellyn Getz, MPH, Director, R&D Patient Partnerships, CSL
Pam Gavin, CEO, NORD
Tré LaRosa, Associate Project Manager, Foundation for the National Institutes of Health
3:15-3:45
 
Linking Bioethics and Patient Centricity Efforts w/ Sustainability, CSR, ESG and Impact Reporting in Life Science Companies:
 How are and should investors, companies and regulators be thinking and communicating about these efforts?
Moderator: Mohit, Partner/Principal, Climate Change and Sustainability Services, EY
Jennifer Evans, Executive Director, Environmental Sustainability & Social Impact, BMS
Smita Pillai, CDO, Regeneron
Jessica Federer, Board Member, Angelini Ventures, Sage Therapuetics, Advisory Board, Yale Blavatnik Fund for Innovation; Member, Yale Institutional Review board
William Stack, ESG, Gilead,
Claudia Carravetta, VP, Corporate Responsibility, President, Abbvie Foundation
Brian Reid,
 
Pharma Pricing and Public Affairs
3:45-4 Break
4-4:25pm 
Small Group Brainstorming Sessions:
 
We will break out into 6 small groups of 10 people each to brainstorm projects, themes/topics, and metrics we should think about collaborating on and developing with the good pharma scorecard to advance bioethics, patient centricity, access, and trustworthiness in medicines development and delivery. Group facilitators:
4:24-4:55pm
 
Full Roundtable Discussions: Where do we go from here? Next steps for advancing, tracking, and communicating patient centricity, trustworthiness, and bioethics progress in pharma.
 
Facilitator: Jennifer Miller
4:55-5pm
 
Closing Remarks
· Jeremy Abbate, Publisher, Scientific American *
confirmed
· Lauren Rogge, Principle, Climate Change and Sustainability, EY
 
*
confirmed
· Arda Ural, Head of Life Sciences, Americas, EY *
confirmed
· Jennifer E. Miller, Co-Director, Associate Professor, Yale School of Medicine, President Bioethics International, Interim-CEO Good Pharma Scorecard
5-6pm Networking and Drinks, with all Participants, sponsored by EY
6-7:30pm Dinner, for speakers and BLF members, sponsored by Bioethics International
About the Roundtable Sponsors + Hosts
Bioethics International (BEI)
 is a 501c3 public charity, founded in 2005, to help advance ethics, trustworthiness, patient-centricity, and social responsibility in healthcare.
EY
. EY’s purpose is building a better working world. The insights and quality services EY provide help build trust and confidence in the capital markets and in economies the world over. They develop outstanding leaders who team to deliver on their promises to all our stakeholders. In so doing, EY plays a critical role in building a better working world for its people, for clients and communities.
Scientific American. 
Scientific American is the authority on science and technology for a general audience, with coverage that explains how research changes our understanding of the world and shapes our lives. First published in 1845, 
Scientific American
 is the longest continuously published magazine in the US. The magazine has published articles by more than 150 Nobel Prize-winning scientists and built a loyal following of influential and forward thinking readers. The archives of 
Scientific American
 include articles penned by Albert Einstein, Thomas Edison, Jonas Salk, Marie Curie, Stephen Hawking, Franklin D. Roosevelt, Stephen Jay Gould, Bill Gates, and more.
Yale Program for Biomedical Ethics. 
The Yale Program for Biomedical Ethics incorporates a diverse group that brings a wide range of experience and expertise to the table, including faculty and staff from the Schools of Medicine, Nursing, Law, Divinity, Public Health, as well as Yale New Haven Hospital staff, and others who share a common interest in education, research, and clinical practice in the field of medical ethics.
 
Our program coordinates the ethics education of Yale medical students over the course of their four years, including assistance for those who choose to write their thesis in this area. In addition, educational programs are provided for other members of the Yale medical community, such as journal clubs, working groups and special conferences.
Good Pharma Scorecard (GPS)
.
 The
 
Good Pharma Scorecard is a ranking and rating of pharmaceutical companies on their bioethics, social responsibility, and patient centricity performance. Through the Scorecard, we develop benchmarks for what constitutes ‘good’ socially responsible practices. We then use these benchmarks to measure and rate company performance annually, helping recognize best practices, catalyze reform where needed, and track progress on goals over time.
Information Source: Yale, EY + Bioethics International | eventbrite

New York

United States

Searching for information and tickets regarding Ethics, Trust + Patient Centricity in Pharma: Defining Metrics for Success | NYC, NY, USA taking place in New York on Jun 24, 2025 (UTC-4)? Trip.com has you covered. Check the dates, itineraries, and other information about Ethics, Trust + Patient Centricity in Pharma: Defining Metrics for Success | NYC, NY, USA now! Trip.com has also prepared more similar exciting activities and discounted flight and hotel packages.

Ethics, Trust + Patient Centricity in Pharma: Defining Metrics for Success | NYC, NY, USA: Tickets, Dates & Itineraries | Trip.com

Ethics, Trust + Patient Centricity in Pharma: Defining Metrics for Success | NYC, NY, USA

Ethics, Trust + Patient Centricity in Pharma: Defining Metrics for Success | Trip.com

null | Trip.com

Spread the word! Share your result with friends and discover their opinions!

The Peninsula New York

Luxury Hotels

Lowell Hotel

Near Aman New York|Upper East Side, New York

The Metropolitan Museum of Art

Best Things to Do

Museums

Themed exhibition halls

M80***23

- Wide variety: collection of 3 million artworks from all over the world, spanning more than 5,000 years of history, covering ancient Egypt, Greece, Rome, Asia, Africa, Oceania and other regions, as well as European paintings, sculptures, decorative arts, etc. There are also a large number of American and modern art works. ​ - Many boutiques: with many famous collections, such as the Danyu Temple in ancient Egypt, China&#39;s &quot;Light Night White&quot; and &quot;Medicinal Buddha Changing Map&quot;, as well as many paintings and sculptures by ancient European masters. Architecture and layout - Majestic exterior: Neoclassical style architectural exterior, solemn and elegant, complements Central Park and becomes one of New York City&rsquo;s iconic cultural buildings. ​-Reasonable layout: 19 exhibition departments are distributed on different floors and regions, the exhibition space is spacious and bright, the exhibits are displayed in an orderly manner, and the focus is on creating a display atmosphere that matches the exhibits, so that the audience can better appreciate and understand the artworks.

Statue of Liberty

Book now for today

Night view

MathewMorais

This is a must do when in NYC, and trip.com has made it easy to enjoy the tour around Liberty Island. The ferry ride was pleasant and the museum has of Statue of Liberty was very informative. The underground is also located close to the ferry station. A good trip to visit Statue of Liberty. Thank you trip.com

The St. Regis New York

Near Trump Tower|New York City Center, New York

New York Edition

Near New York University|Gramercy, New York

Four Seasons Hotel New York

Empire State Building

Immediate access

- Art Deco style: The Empire State Building adopts a typical Art Deco style, emphasizing symmetry, geometry and fine decoration, and the top minarets are uniquely designed to make them exceptionally strong and unique in the New York skyline. ​- Fine structural design: The backbone of the building is composed of 210 steel columns, of which 12 directly reach the top of the building, providing a solid support for the building. With the increase of height, the floor area gradually shrinks, forming five major changes, this design not only considers structural stability, but also increases the aesthetic of the building. Historical and Cultural Values - Witnessing Historical Changes: The Empire State Building was built during the Great Depression of the 1930s, and its completion not only provided a large number of jobs in the United States at the time, but also marked the beginning of the rise of American industry and the peak of modern urban development. ​- Bearing cultural symbols: As one of the cultural symbols of the United States, the Empire State Building has appeared in many films, literature and art works, such as the film &quot;King Kong&quot;, further enhancing its global visibility and cultural influence.

The Museum of Modern Art

ryne.srj

a must mustsee in new york! such a nice and big museum to learn about history and art! arrive early though

Central Park

Fall Viewing Attractions

蓝星旅行者

Walking through New York&#39;s Central Park, it seems to fall into the gentle cracks of the steel forest. Morning light penetrates the forest, spreads powder and white brocade on the cherry blossom avenue, the wind is outdated petals fall, and the corners of the skyscraper soften into a background sound in the flower shadow. The city code on the bench is the most moving. The cold chair was stroked by the fingertips, and the short text on the nameplate hid the New Yorker&#39;s temperature: &quot;Give my wife Carol, because she loves Central Park, and I love her&quot; - the separation of life, the young encounter, the mother and son bonding, all condensed into a dew in the wood grain. When high school students spread out books and laughed on the sheep lawn, and when the reciting of Shakespeare&rsquo;s poems drifted from Cherry Hill to the lake, the park became an emotional resonant box, full of human narratives that transcended language. In the afternoon, I closed my eyes in the Ramble Forest area. Bird song and stream sound woven into natural white noise, suddenly understand the deep meaning of Olmsted: this 3.4 million square meters of green lung, originally dedicated to &quot;the handicrafts of tired industrial workers&quot;, so that people who can not travel far can drink nature here. The boat house pier at dusk is the most magical, The wooden paddles smashed the red-stained lake, and the wild ducks swam through the reflection of Manhattan. The hustle and bustle of the city sank to the bottom, leaving only the breathing in the shadow of the oasis of the oars. &quot;When the whispers of the bench fell into the palms with the cherry blossom rain, I knew that the oasis in this concrete wasteland, It was New York&#39;s prose poem to the world. &quot;&nbsp;

Time:	Jun 24, 2025 (UTC-4) ENDED
Location:	NYC, NY, USA

Ethics, Trust + Patient Centricity in Pharma: Defining Metrics for Success | NYC, NY, USA

Details

Vote

Are you interested in Ethics, Trust + Patient Centricity in Pharma: Defining Metrics for Success?

Recommended Products for Ethics, Trust + Patient Centricity in Pharma: Defining Metrics for Success | NYC, NY, USA

The Peninsula New York

Lowell Hotel

The Metropolitan Museum of Art

Statue of Liberty

The St. Regis New York

New York Edition

Four Seasons Hotel New York

Empire State Building

The Museum of Modern Art

Central Park

Ethics, Trust + Patient Centricity in Pharma: Defining Metrics for Success | NYC, NY, USA

Details

Vote

Are you interested in Ethics, Trust + Patient Centricity in Pharma: Defining Metrics for Success?

Recommended Products for Ethics, Trust + Patient Centricity in Pharma: Defining Metrics for Success | NYC, NY, USA

The Peninsula New York

Lowell Hotel

The Metropolitan Museum of Art

Statue of Liberty

The St. Regis New York

New York Edition

Four Seasons Hotel New York

Empire State Building

The Museum of Modern Art

Central Park

More contents about New York